JPMorgan Chase & Co. Sells 152,477 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
JPMorgan Chase & Co. trimmed its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 39.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 234,667 shares of the biopharmaceutical company’s stock after selling 152,477 shares during the quarter. JPMorgan […]
